Peripheral T lymphocyte and immunocyte subset dynamics: markers of neoadjuvant therapy outcomes in esophageal squamous cell carcinoma

Peripheral T lymphocyte and immunocyte subset dynamics: markers of neoadjuvant therapy outcomes in esophageal squamous cell carcinoma

PurposeIn patients with resectable esophageal squamous cell carcinoma (ESCC), neoadjuvant therapy increased the curative resection rate, disease-free survival, and overall survival for patients with resectable ESCC. However, the efficacy of neoadjuvant therapy varies among different patients. We aim...

Full description

Bibliographic Details
Main Authors:	Xin Nie, Shuya He, Xinming Nie, Changding Li, Kunyi Du, Wenwu He, Zhiyu Li, Kunhan Ni, Simiao Lu, Chenghao Wang, Kangning Wang, Yan Miao, Longlin Jiang, Jiahua Lv, Guangyuan Liu, Qiang Fang, Lin Peng, Wenguang Xiao, Qifeng Wang, Dongsheng Wang, Yongtao Han, Xuefeng Leng
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-12-01
Series:	Frontiers in Immunology
Subjects:	esophageal squamous cell carcinoma neoadjuvant chemoradiotherapy lymphocyte subsets peripheral blood cell major pathological response
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1320282/full

Similar Items

Tislelizumab Plus Chemotherapy Sequential Neoadjuvant Therapy for Non-cCR Patients After Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma (ETNT): An Exploratory Study
by: Wenwu He, et al.
Published: (2022-06-01)

Longitudinal analysis of immunocyte responses and inflammatory cytokine profiles in SFTSV-infected rhesus macaques
by: Yi-Hui Li, et al.
Published: (2023-03-01)

The impact of limited lymphadenectomy-caused occult lymph node metastasis on patients with node-negative esophageal carcinoma
by: Zhiyu Li, et al.
Published: (2023-12-01)

The predictive value of peripheral blood cells and lymphocyte subsets in oesophageal squamous cell cancer patients with neoadjuvant chemoradiotherapy
by: Jin Zhou, et al.
Published: (2022-11-01)

Reliability and safety of minimally invasive esophagectomy after neoadjuvant chemoradiation: a retrospective study
by: Guangyuan Liu, et al.
Published: (2019-05-01)

Clinical value of folate receptor-positive circulating tumor cells in patients with esophageal squamous cell carcinomas: a retrospective study
by: Qiang Zhou, et al.
Published: (2023-11-01)

ImmuCellAI: A Unique Method for Comprehensive T‐Cell Subsets Abundance Prediction and its Application in Cancer Immunotherapy
by: Ya‐Ru Miao, et al.
Published: (2020-04-01)

The double roles of T cell-mediated immune response in the progression of MASLD
by: Zigan Li, et al.
Published: (2024-04-01)

Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study
by: Li Jiang, et al.
Published: (2022-12-01)

The efficacy and safety of neoadjuvant immunotherapy in resectable locally advanced esophageal squamous cell carcinoma: A systematic review and meta-analysis
by: Wenwu He, et al.
Published: (2023-02-01)

Immunocyte Membrane-Coated Nanoparticles for Cancer Immunotherapy
by: Ping Gong, et al.
Published: (2020-12-01)

Circulating lymphocyte subsets are prognostic factors in patients with nasopharyngeal carcinoma
by: Jing Zhu, et al.
Published: (2022-06-01)

Biological Characteristics and Antitumor Activity of CIK Cells Activated by Recombinant Human Fibronectin for Human Lung Cancer Cell Lines In Vitro
by: Jialing WANG, et al.
Published: (2010-04-01)

Single-cell landscape of immunocytes in patients with extrahepatic cholangiocarcinoma
by: Lei Xu, et al.
Published: (2022-05-01)

Interleukin 35 induced Th2 and Tregs bias under normal conditions in mice
by: Xiaoning Zhang, et al.
Published: (2018-09-01)

The Effect of the Surgical Margins on the Outcome of Patients with Head and Neck Squamous Cell Carcinoma: Single Institution Experience
by: Hany Eldeeb, et al.
Published: (2012-03-01)

The Effect of the Surgical Margins on the Outcome of Patients with Head and Neck Squamous Cell Carcinoma: Single Institution Experience
by: Hany Eldeeb, et al.
Published: (2012-03-01)

Naringenin Modifies the Development of Lineage-Specific Effector CD4+ T Cells
by: Junpeng Wang, et al.
Published: (2018-10-01)

Immune cell subset differentiation and tissue inflammation
by: Pu Fang, et al.
Published: (2018-07-01)

Reduction of Peripheral Blood iNKT and γδT Cells in Patients With Parkinson's Disease: An Observational Study
by: Chao Zhou, et al.
Published: (2020-06-01)

Immunocytes Rapid Responses Post-ischemic Stroke in Peripheral Blood in Patients With Different Ages
by: Haiyue Zhang, et al.
Published: (2022-05-01)

Age-related changes in peripheral T-cell subpopulations in elderly individuals: An observational study
by: Quan Xiao-Qing, et al.
Published: (2023-02-01)

EVALUATION OF T LYMPHOCYTE SUBSETS IN CHILDREN WITH BETA THALASSEMIA MAJOR
by: A. Danesh, et al.
Published: (1999-06-01)

Serum and Peritoneal Fluid Cytokine Profiles in Infertile Women with Endometriosis
by: Majid Tarokh, et al.
Published: (2019-06-01)

EVALUATION OF T LYMPHOCYTE SUBSETS IN CHILDREN WITH BETA THALASSEMIA MAJOR
by: A. Danesh, et al.
Published: (1999-07-01)

Imbalanced Immune Response of T-Cell and B-Cell Subsets in Patients with Moderate and Severe COVID-19
by: Alexey Golovkin, et al.
Published: (2021-09-01)

Age Distribution of Multiple Functionally Relevant Subsets of CD4+ T Cells in Human Blood Using a Standardized and Validated 14-Color EuroFlow Immune Monitoring Tube
by: Vitor Botafogo, et al.
Published: (2020-02-01)

Association of the tissue infiltrated and peripheral blood immune cell subsets with response to radiotherapy for rectal cancer
by: Min Zhu, et al.
Published: (2022-05-01)

Firsthand experience of chemoradiotherapy in patients with localized small cell lung cancer. Retrospective assessment
by: A. E. Kuzminov, et al.
Published: (2020-07-01)

THYROID STATUS AND ITS CORRELATION WITH THE FUNCTIONAL ACTIVITY OF IMMUNOCYTES
by: V. V. Zdor, et al.
Published: (2017-07-01)

A retrospective study comparing definitive chemoradiotherapy vs. chemoradiotherapy followed by surgery in T4 esophageal squamous cell carcinoma patients who were downstaged after neochemoradiotherapy
by: Tian Zhang, et al.
Published: (2022-08-01)

Circulating CD8+ T Cell Subsets in Primary Sjögren’s Syndrome
by: Igor Kudryavtsev, et al.
Published: (2023-10-01)

Long-term treatment outcomes/toxicities of definite chemoradiotherapy (intensity-modulated radiation therapy) for early-stage “bulky” cervical cancer and survival impact of histological subtype
by: He-Yuan Hsieh, et al.
Published: (2023-03-01)

Altered Distribution of Circulating T Follicular Helper-Like Cell Subsets in Rheumatoid Arthritis Patients
by: Rui Su, et al.
Published: (2021-07-01)

Reduced CD4+T Cell CXCR3 Expression in Patients With Allergic Rhinitis
by: Xiaofeng Yu, et al.
Published: (2020-11-01)

Alterations in B Cell and Follicular T-Helper Cell Subsets in Patients with Acute COVID-19 and COVID-19 Convalescents
by: Igor V. Kudryavtsev, et al.
Published: (2021-12-01)

Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for stage IV esophageal squamous cell carcinoma: a retrospective controlled study
by: Jiahua Lyu, et al.
Published: (2018-11-01)

A Multicenter Retrospective Cohort Series of Muscle-invasive Bladder Cancer Patients Treated with Definitive Concurrent Chemoradiotherapy in Daily Practice
by: Ben-Max de Ruiter, et al.
Published: (2022-05-01)

The capability of heterogeneous γδ T cells in cancer treatment
by: Wenyi Yan, et al.
Published: (2023-11-01)

Acellular Wharton’s Jelly, Potentials in T-Cell Subtypes Differentiation, Activation and Proliferation
by: Mehdi Talebi, et al.
Published: (2020-08-01)